Basit öğe kaydını göster

A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease

dc.contributor.authorGül, Ahmet
dc.contributor.authorBatu, Ezgi D.
dc.contributor.authorCANNA, Scott W.
dc.contributor.authorGO, Ellen
dc.contributor.authorHOFFMANN, Patrycja
dc.contributor.authorLeavis, Helen L.
dc.contributor.authorÖZEN, SEZA
dc.contributor.authorSCHWARTZ, Daniella M.
dc.contributor.authorSTONE, Deborah L.
dc.contributor.authorvan Royen-Kerkof, Annet
dc.contributor.authorKASTNER, Daniel L.
dc.contributor.authorAKSENTIJEVICH, Ivona
dc.contributor.authorLaxer, Ronald M.
dc.contributor.authorAeschlimann, Florence A.
dc.date.accessioned2021-03-04T11:22:17Z
dc.date.available2021-03-04T11:22:17Z
dc.date.issued2018
dc.identifier.citationAeschlimann F. A. , Batu E. D. , CANNA S. W. , GO E., Gül A., HOFFMANN P., Leavis H. L. , ÖZEN S., SCHWARTZ D. M. , STONE D. L. , et al., "A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease", ANNALS OF THE RHEUMATIC DISEASES, cilt.77, sa.5, ss.728-735, 2018
dc.identifier.issn0003-4967
dc.identifier.otherav_72049371-328d-4172-87b8-71dbba53d909
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/78476
dc.identifier.urihttps://doi.org/10.1136/annrheumdis-2017-212403
dc.description.abstractObjectives The association between mutations in TNFAIP3, encoding the NF-kB regulatory protein A20, and a new autoinflammatory disease has recently been recognised. This study aims at describing the clinical phenotypes and disease course of patients with A20 haploinsufficiency (HA20).
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleA20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease
dc.typeMakale
dc.relation.journalANNALS OF THE RHEUMATIC DISEASES
dc.contributor.departmentUniversity Of Toronto , ,
dc.identifier.volume77
dc.identifier.issue5
dc.identifier.startpage728
dc.identifier.endpage735
dc.contributor.firstauthorID51165


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster